Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. by Vassall, Kenrick A et al.
Western University
Scholarship@Western
Biochemistry Publications Biochemistry Department
2-8-2011
Decreased stability and increased formation of
soluble aggregates by immature superoxide
dismutase do not account for disease severity in
ALS.
Kenrick A Vassall
Helen R Stubbs
Heather A Primmer
Ming Sze Tong
Sarah M Sullivan
See next page for additional authors
Follow this and additional works at: https://ir.lib.uwo.ca/biochempub
Part of the Biochemistry Commons
Citation of this paper:
PMID: 21257910
Authors
Kenrick A Vassall, Helen R Stubbs, Heather A Primmer, Ming Sze Tong, Sarah M Sullivan, Ryan Sobering,
Saipraveen Srinivasan, Lee-Ann K Briere, Stanley D Dunn, Wilfredo Colón, and Elizabeth M Meiering
This article is available at Scholarship@Western: https://ir.lib.uwo.ca/biochempub/168
Decreased stability and increased formation of soluble
aggregates by immature superoxide dismutase
do not account for disease severity in ALS
Kenrick A. Vassalla,1, Helen R. Stubbsa,1, Heather A. Primmera, Ming Sze Tonga, Sarah M. Sullivana, Ryan Soberinga,2,
Saipraveen Srinivasanb, Lee-Ann K. Brierec, Stanley D. Dunnc, Wilfredo Colónb, and Elizabeth M. Meieringa,3
aGuelph-Waterloo Centre for Graduate Studies in Chemistry and Biochemistry and Department of Chemistry, Waterloo, ON, Canada N2L 3G1;
cDepartment of Biochemistry, University of Western Ontario, London, ON, Canada N6A 5C1; and bDepartment of Chemistry and Chemical Biology,
Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180
Edited by Alan R. Fersht, Media Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom, and approved December 6, 2010 (received for
review November 11, 2009)
Protein aggregation is a hallmark of many diseases, including
amyotrophic lateral sclerosis (ALS), where aggregation of Cu/Zn
superoxide dismutase (SOD1) is implicated in causing neurodegen-
eration. Recent studies have suggested that destabilization and
aggregation of the most immature form of SOD1, the disulfide-
reduced, unmetallated (apo) protein is particularly important in
causing ALS. We report herein in depth analyses of the effects
of chemically and structurally diverse ALS-associated mutations
on the stability and aggregation of reduced apo SOD1. In contrast
with previous studies, we find that various reduced apo SOD1 mu-
tants undergo highly reversible thermal denaturation with little
aggregation, enabling quantitative thermodynamic stability ana-
lyses. In the absence of ALS-associated mutations, reduced apo
SOD1 is marginally stable but predominantly folded. Mutations
generally result in slight decreases to substantial increases in the
fraction of unfolded protein. Calorimetry, ultracentrifugation,
and light scattering show that all mutations enhance aggregation
propensity, with the effects varying widely, from subtle increases
in most cases, to pronounced formation of 40–100 nm soluble
aggregates by A4V, a mutation that is associated with particularly
short disease duration. Interestingly, although there is a correlation
between observed aggregation and stability, there is minimal to no
correlation between observed aggregation, predicted aggregation
propensity, and disease characteristics. These findings suggest that
reduced apo SOD1 does not play a dominant role in modulating
disease. Rather, additional and/or multiple forms of SOD1 and
additional biophysical and biological factors are needed to account
for the toxicity of mutant SOD1 in ALS.
Mutations in Cu,Zn superoxide dismutase (SOD1) causefamilial amyotrophic lateral sclerosis (fALS), a devas-
tating and invariably fatal neurodegenerative disease. Although
accounting for only a small percentage of all ALS cases, SOD1
mutations represent one of the main known causes of the disease.
The similar symptoms and pathology of familial and sporadic
ALS suggest common disease mechanisms and the potential
for related therapeutic strategies (1–3). The mechanisms by
which mutant SOD1 causes ALS are not known; however, exten-
sive evidence supports a toxic gain of function due to increased
aggregation of mutant protein. Misfolding and aggregation of
diverse proteins are observed in numerous diseases, including
other neurodegenerative diseases such as Alzheimer’s, Hunting-
ton, and prion diseases (1, 2). Amyloid is a type of aggregate
structure formed by many disease-associated proteins, and per-
haps by all proteins, often under destabilizing conditions (4).
Although there has been some controversy concerning the amy-
loid-like nature of large insoluble aggregates in mutant SOD1
mice models of ALS, amyloid aggregates are not observed in
ALS patients (5–7). Here, we characterize the formation of small,
soluble, nonamyloid aggregates by mutant SOD1.
In its mature form, SOD1 is a highly stable, homodimeric pro-
tein, with each subunit binding one catalytic copper ion and one
structural zinc ion, and containing one intramolecular disulfide
bond as well as two nonconserved free cysteines (Fig. S1A).
Numerous in vivo and in vitro studies have shown that various im-
mature, destabilized forms of SOD1 are prone to aggregate, and
this is often enhanced by disease-associated mutations (8–16).
Recently, attention has focused on aggregation of the most imma-
ture form of SOD1, in which the disulfide bond is reduced and no
metals are bound (reduced apo). Studies of various mutant-SOD1
ALSmicemodels have shown that small, soluble, misfolded forms
of reduced apo SOD1 are enriched in the spinal cord and may be
the common cytotoxic species that cause ALS (17, 18). In addi-
tion, cell culture studies suggest that ALS-associated mutations
can promote disulfide bond reduction and metal loss (19). Rela-
tively little is known, though, about the properties of reduced
apo SOD1, and how mutations affect these properties. In vitro
studies have shown that agitation and/or oxidation of reduced
apo SOD1 results in the formation of large, insoluble, amyloid
aggregates (8, 10). However, the relevance of amyloid formation
to ALS is questionable, and recent studies of mutant-SOD1 mice
models have shown that formation of aberrant intermolecular
disulfide bonds and large insoluble aggregates by SOD1 becomes
pronounced only in the final, symptomatic stages of disease (13).
There is also extensive evidence that smaller, soluble aggregates
are particularly neurotoxic (2). Thus, it is of central importance to
elucidate the properties of reduced apo SOD1s, and how these
may relate to pathogenic mechanisms.
We report here in depth analyses of the effects of chemically
and structurally diverse ALS-associated mutations on the stability
and aggregation of reduced apo SOD1, under physiologically
relevant quiescent, reducing conditions. Themutations are predo-
minantly destabilizing, causing marked changes in the fraction of
protein that is unfolded and increasing the propensity of the pro-
tein to form soluble aggregates. However, the formation of these
aggregates is not well correlated with disease duration. Although
the results suggest that aggregation of reduced apo SOD1 may
play some role in disease, they do not support increased aggrega-
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tion of reduced apo mutants as the dominant determinant of ALS
severity. Rather, multiple immature or aberrant forms of SOD1
are implicated in playing important roles in modulating disease.
Results
For most experiments herein, we employed a well-established
pseudo WT (pWT) construct in order to facilitate measurements
of stability and aggregation of reduced apo SOD1s and avoid com-
plications caused by aberrant disulfide bond formation (8, 14–16,
20–22). In pWT, the nonconserved free cysteines at residues 6 and
111 are replaced by alanine and serine, respectively, whereas the
highly conserved cysteines at residues 57 and 146 are retained
(Fig. S1A). Cysteines 57 and 146 form a disulfide bond in mature
forms of SOD1 but are reduced in the current study. pWT is a
suitable background because its activity, structure, and stability
are extremely similar to wild type, and use of this background
formerly enabled thermodynamic stability analyses for disulfide-
oxidized holo and apo SOD1s (15, 16, 23, 24). In various in vivo
and in vitro studies, the free cysteines are frequently but not
always observed to form aberrant disulfide bonds in aggregates,
and they have been suggested to also play subtle roles in modulat-
ing noncovalent interactions during aggregation (8, 9, 11–14, 25).
These effects were controlled for here by analyzing the properties
of mutations relative to the pWT background in the absence of
disulfide bond formation. In addition, we conducted some experi-
ments using the WT background containing cysteines 6 and 111;
the results obtained are consistent with those obtained using pWT.
All experiments on reduced apo SOD1s were conducted
under physiologically relevant conditions of pH (20 mM Hepes,
pH 7.4) and protein concentration (∼30–60 μM monomer,
0.5–1.0 mgmL−1) (11, 26), under reducing conditions [1 mM
Tris(2-carboxyethyl)phosphine (TCEP)], with no agitation and
sample incubation under anaerobic conditions. The reduced sta-
tus of the protein throughout all experiments was confirmed
by iodoacetamide modification of the reduced cysteines followed
by SDS-PAGE (Fig. S1B) (11).
In the Absence of ALS-Associated Mutations, Reduced apo SOD1
Unfolds with High Reversibility at Well Above Physiological Tempera-
ture. The stability of reduced apo pWT and WT SOD1 were
measured by differential scanning calorimetry (DSC) (Figs. 1 A
and B, 2D, and Table S1), which shows that the temperature of
maximum heat capacity (Cp), tm;app, is ∼48 °C for both constructs.
The tm;app for reduced apo SOD1 is markedly lower compared
to those for the more mature disulfide-oxidized apo and holo
forms (Fig. 1A) (15, 16). However, despite being significantly less
stable, reduced apo pWT thermally unfolds with high reversibil-
ity, typically ∼95% (Fig. 1B), comparable to the reversibility for
disulfide-oxidized forms of SOD1 (15, 23, 24). The reversibility
for the WT (Fig. 2D) is somewhat lower, at ∼75%, likely due
to the presence of the free thiols that have been shown previously
to decrease reversibility due to the formation of aberrant disul-
fide bonds (27). To minimize inaccuracies due to irreversibility,
pWT was used for most of the further analyses.
Thermodynamic Analysis Under Physiologically Relevant Conditions
Shows Reduced apo SOD1 Undergoes a Monomer Two-State Unfolding
Transition and Is Predominantly Folded.High reversibility of unfold-
ing is a prerequisite for thermodynamic analysis, which has not
been reported previously for reduced apo SOD1. In previous stu-
dies, we showed that disulfide-oxidized apo and holo pWT SOD1
thermally unfold with high reversibility according to a two-state
dimer unfolding mechanism (15); however, reduction or muta-
tion of the disulfide bond in apo SOD1 greatly weakens the dimer
interface (26, 28, 29). Measurements of thermal unfolding for
reduced apo pWTare consistent with a monomer unfolding tran-
sition, showing no systematic shift in tm;app over ∼20-fold range in
protein concentration (7–152 μM, 0.1–2.4 mgmL−1) (Fig. S2A).
The unfolding data for pWTare well fit using a two-state mono-
mer unfolding model (Table 1 and SI Text), with an average van’t
Hoff to calorimetric enthalpy ratio (ΔHvH∕ΔHcal) of 1.1 0.2
(Table 1 and Table S1), further confirming the applicability of the
two-state monomer model (30). Similar fits are obtained for WT
(Fig. 2E, Table 1, and Table S1).
Calculation of the temperature dependence of stability requires
knowledge of the change in heat capacity upon unfolding, ΔCp
(SI Text), which was determined by Kirchoff analysis (31) to be
1.1 0.1 kcalmol−1 °C−1 for reduced apo pWT (Fig. S2 B and C).
This value is relatively low compared to that expected for a protein
of this size, ∼2 kcalmol−1 °C−1 (32, 33), suggesting that the reduced
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Fig. 1. Reversible thermal unfolding of reduced apo pWT SOD1. (A) DSC
scans of pWT SOD1 in the reduced apo form in 20 mM Hepes, 1 mM TCEP,
pH 7.4 and the disulfide-intact apo and holo forms in 20 mM Hepes, pH 7.8.
The dashed black line indicates physiological temperature. (B) Consecutive
thermal unfolding traces of disulfide-intact apo pWT SOD1 in which the sam-
ple was heated (solid black line), cooled and heated again (dashed gray line).
(C) Change in apparent tm of apo SOD1 in the disulfide-oxidized (light shaded
bars) and the disulfide-reduced form (dark shaded bars). (D) Fraction of
unfolded reduced apo mutant SOD1 at 37 °C, calculated from thermody-
namic parameters (Table 1 and SI Text).
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Fig. 2. Reversibility and data fitting of reduced apomutants. The dashed black
line indicates physiological temperature. (A) Consecutive thermal unfolding
endothermsof reducedapomutantswith lowunfolding reversibility and (B)with
high unfolding reversibility (scan 1—solid black line; rescan—large dashed gray
line). (C) DSC data fitting of the reduced apo mutants and pWT. Typical thermo-
grams (solid black lines) with corresponding two-state monomer fits (small
dashed gray lines) are shown. (D) Consecutive thermal unfolding endotherms
of WT and wtH46R (scan 1—solid black line; rescan—large dashed gray line).
(E)DSCdata fittingofWTandwtH46RSOD1.Thermograms(solidblack lines)with
corresponding two-state monomer fits (small dashed gray lines) are shown.
In each panel, the datasets are offset for clarity.
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apomonomer may be less structured than a typical globular protein.
The Gibbs free energy of unfolding, ΔG, calculated from the ther-
modynamic parameters is 3.5 0.1 and 1.8 0.1 kcalmol−1 at
25 °C and 37 °C, respectively (Table 1). Similar values were obtained
for WTand are given in Table 1.
An independent measure of ΔG was obtained for pWT using
CD-monitored equilibrium urea chemical denaturation and rena-
turation curves (Fig. S2D and E and Table 1). These data are also
well fit by a two-state monomer unfolding transition, giving a ΔG
of 4.0 0.2 kcalmol−1 at 25 °C, which is in reasonable agreement
with the value obtained by DSC, and previous chemical denatura-
tion experiments for reduced apo WT at pH 6.3 (29).
Knowledge ofΔG enables calculation of the fraction of protein
that is unfolded, fU (SI Text). For pWT at 37 °C, f U is ∼0.05
(Fig. 1D), showing that the protein is predominantly (95%)
folded. However, owing to the relatively low value of ΔG, f U is
very sensitive to small perturbations in stability caused by muta-
tion, as described below.
DSC Reveals Complex Effects of ALS-Associated Mutations on the
Stability and Aggregation Propensity of Reduced apo SOD1. The
effects of chemically and structurally diverse ALS-associated
SOD1 mutations on both the disulfide-oxidized and reduced apo
forms of the protein were also analyzed by DSC. The mutations
include A4V, Tand S, and V148I, located in the dimer interface;
G37R and H43R, affecting the packing of residues in the beta
barrel; metal binding mutants H46R and G85R; G93R, S, A,
and D at a mutational hot-spot within a tight turn; and E100G
located at the end of strand 6, which eliminates a salt bridge
with K30 (Fig. S1A). All of the mutants produced measurable
thermograms (Fig. 2 A and B and Table S2), except G93D.
Based on lower tm;app values, the mutants are generally desta-
bilized relative to pWT, except for H46R and V148I, which have
slightly increased stabilities (Fig. 1C and Table S2). Furthermore,
in the reduced apo form all mutants except H46R, V148I, and
G85R have tm;app values at or below 37 °C (Table S2). This is in
contrast to the more mature disulfide-oxidized apo form where
the mutants all have tm;app values significantly higher than 37 °C
(15, 24). Although it is difficult to directly compare the effects
of the mutations on the thermodynamic stability of the oxidized
to the reduced apo forms due to the change in quaternary struc-
ture, it is noteworthy that the changes in melting temperature are
larger in the reduced apo form compared to the oxidized apo
form (Fig. 1C and Table S2). Similarly, the effects of mutations
in nonmetal binding mutants are larger in the oxidized apo forms
than in the holo (metallated) forms (15), suggesting that the
effects of mutations in SOD1 tend to propagate more as the pro-
tein becomes increasingly destabilized and folding becomes less
cooperative. Overall, the propensity of most reduced apo SOD1s
to misfold/aggregate is evident from the decreased reversibility
of thermal unfolding traces (Fig. 2A), which is generally most
pronounced in the significantly destabilized mutants.
Nevertheless, the reversibility of thermal unfolding is remark-
ably high for several mutants: H46R, V148I, G85R, and E100G,
enabling thermodynamic analysis using the two-state monomer
unfolding model (Fig. 2 B and C, Table 1, and Table S1). Similar
results were also obtained for H46R in the WT background
(Fig. 2 D and E, Table 1, and Table S1). The stability of pWTand
H46R was also measured using chemical denaturation, again
giving results consistent with those obtained by DSC (Fig. S2 D
and E and Table 1). Using the fitted thermodynamic parameters,
f U at 37 °C is calculated to be 0.05, 0.007, 0.03, 0.28, and 0.71
for pWT, H46R, V148I, G85R, and E100G, respectively (Fig. 1D
and SI Text). Thus, at physiological temperature the slightly stabi-
lizing H46R andV148Imutants are predominantly folded (in fact,
more so thanpWT), but the proportionof unfoldedprotein ismark-
edly increased for the other destabilizing mutants, with E100G
being more unfolded than folded. This differs significantly from
theeffects of themutations in thedisulfide-oxidizedapo formwhere
the proteins remain very predominantly folded (Table S2) (24).
Although the thermal unfolding of these reduced apo SOD1s is
highly reversible, there is someevidence in theDSCfittedparameters
for increased aggregation propensity (15). H46R, G85R, and V148I
have relatively low,mostly negative, fittedΔCps, with average values
of −0.42 0.84, −2.62 1.19, and −0.11 0.34 kcalmol−1 °C−1,
respectively (Table 1). The negative average ΔCps for H46R and
V148I is pronounced and consistent, suggesting the occurrence
of exothermic aggregation as these mutants thermally unfold (15).
In contrast, E100G does not exhibit unusually lowΔCp values; how-
ever, the ΔHvH∕ΔHcal ratios tend to be larger than 1 (1.3 0.1
on average), suggesting a larger cooperative unfolding unit, i.e., pre-
sence of aggregates (34). Overall, the DSC data are suggestive of
subtle increases in aggregation of all mutant SOD1s.
Analytical Ultracentrifugation Shows That Reduced apo SOD1s Are
Predominantly Monomeric, and Mutations Slightly Increase Protein–
Protein Interactions. In order to further investigate the tendency
of reduced apo SOD1s to aggregate, analytical ultracentrifugation
(AUC) sedimentation velocity and equilibrium experiments were
performed (SI Text). Sedimentation velocity experiments can assess
sample heterogeneity with high sensitivity. Analysis of the velocity
data for pWTandH43R revealed species with sedimentation coeffi-
cients of 1.5–2 S (Fig. S3), very similar to the values reported
previously for reduced apo WT SOD1 (28). The plots of boundary
fraction versus sedimentation coefficient show only a modest slope,
indicating no significant population of dimers or larger aggregated
species for either pWTor H43R in these experiments.
Sedimentation equilibrium experiments at several rotor speeds
(20,000, 25,000, 30,000, and 35,000 rpm) were also performed to
analyze the molecular weights (MWs) of the species present in
solution. Fitting of the equilibrium data for pWT, H43R, A4V,
Table 1. Summary of thermodynamic parameters for reduced apo SOD1s
apo reduced SOD*
tm,
°C
ΔHvH,
kcal mol−1 ΔHvH∕ΔHcal
ΔCp,
kcal mol−1 °C−1
ΔG,†,‡,
25 °C, kcal mol−1
ΔG,†
37 °C, kcal mol−1
ΔΔG,§
37 °C, kcal mol−1
pWT 47.6 ± 0.5 50.5 ± 1.6 1.14 ± 0.15 0.72 ± 0.57 3.5 ± 0.1 4.0 ± 0.2 1.8 ± 0.1 N/A
H46R 52.6 ± 0.5 56.1 ± 4.2 0.95 ± 0.08 −0.42 ± 0.84 4.9 ± 0.1 5.1 ± 0.1 3.1 ± 0.1 +1.3
V148I 51.0 ± 1.1 58.4 ± 2.6 0.93 ± 0.04 −2.62 ± 1.19 3.6 ± 0.1 2.2 ± 0.0 +0.4
G85R 40.7 ± 0.4 46.9 ± 1.8 1.06 ± 0.36 −0.11 ± 0.34 2.1 ± 0.1 0.6 ± 0.0 −1.2
E100G 33.2 ± 1.2 47.3 ± 2.0 1.27 ± 0.06 0.79 ± 0.32 1.0 ± 0.1 −0.6 ± 0.2 −2.4
WT 46.8 ± 0.4 57.2 ± 1.1 1.49 ± 0.27 1.01 ± 0.67 3.0 ± 0.0 1.6 ± 0.0 N/A
wtH46R 52.7 ± 2.5 57.4 ± 5.4 0.76 ± 0.22 −1.59 ± 3.18 3.8 ± 0.5 2.4 ± 0.4 +0.8
N/A, not applicable.
All values are averages and standard deviations from at least three samples (Table S1), excluding WT and V148I, which are averaged over two samples.
*All mutants are in the pWT background unless otherwise specified.
†Values are calculated using the thermodynamic parameters obtained from the monomer two-state model and a temperature independent ΔCp of 1.1
0.1 kcalmol−1 °C−1 (Fig. 2 B and C).
‡Values in italics are from monomer two-state unfolding fits of equilibrium urea chemical denaturation curves (Fig. S2 D and E).
§ΔΔG ¼ ΔGðmutantÞ-ΔGðpWTÞ.
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and E100G to a single species model gave highly reproducible
results (Table S3). For the pWT protein, the fitted MWat lower
rotor speeds is generally close to 15 kDa, just under the calculated
mass of ∼15.8 kDa. In contrast to the pWT, the fitted MWs for
the A4Vand E100Gmutants are intermediate between monomer
and dimer, whereas fits for the mutant H43R tend to give values
closer to what would be expected for a dimer. Additionally, fitted
MW values for all mutants markedly decrease with increased
rotor speed (Table S3). These results clearly indicate increased
intermolecular association of the mutant proteins. Attempts to
fit the data to two-state models for monomer/dimer, monomer/
trimer, and monomer/tetramer transitions gave poor fits with
nonrandom residuals, indicating that the association is likely
more complex than a simple two-state process. Overall, the sedi-
mentation equilibrium data indicate that the pWT protein
remains predominantly monomeric during the lengthy period
required for these studies, but that the mutants have an increased
tendency to form small aggregated species. These findings are
consistent with the results of the DSC experiments.
Light Scattering Reveals Marked Differences in Aggregation of
Mutants upon Prolonged Incubation.Dynamic light scattering (DLS)
was used to monitor the size of particles in solution upon incubating
samples at 37 °C (Fig. 3 and Figs. S4 and S5A). It is important to
note that light scattering intensity is proportional to the sixth power
of the diameter of the scattering particle; thus this technique is
extremely sensitive to aggregate formation (35). DLS analyses
showed that all reduced apo SOD1 solutions were initially monodis-
perse,witha single speciesofhydrodynamicdiameter∼5–6 nm.This
diameter is intermediate between those expected for a protein the
size of SOD1 in the fully folded and unfolded states (36), consistent
with the relatively low ΔCp (see above), and suggesting that the
folded reduced apo SOD1 may have an expanded structure.
Upon prolonged incubation, gradual formation of small amounts
of solubleaggregateswas observed,withdistinct differences between
mutants (Fig. 3 and Figs. S4 and S5). At one extreme, H46R and
V148I showonly very slight evidence for aggregation,withmore than
99%of the protein remaining as reducedmonomers after∼300 h of
incubation (Fig. 3D and S4D). In contrast, A4VandH43R show the
most pronounced evidence of soluble aggregates species (Fig. 3 C
and F). A4V forms aggregates with hydrodynamic diameters of
40–60 nmwithin∼15 h of incubation, and these approximately dou-
ble in diameter and increase in abundance over ∼2 weeks. H43R
forms 100–1,000 nm species within ∼60 h, which also increase in
abundance with time. For both mutants, at long incubation times
the larger species dominate the scattering and the solublemonomers
can no longer be observed. However, the total intensity of scat-
tered light continues to increase, indicating continued aggrega-
tion (Fig. S5B). In general, the extent of aggregation of different
mutants, as shown by the prominence of large species in the size
distributions (Fig. 3 and Figs. S4 and S5A), is consistent with the
extent of aggregation as indicated by total light scattering intensity
(Fig. S5 B–D). Both observations give similar indications of the
relative aggregation propensities of different mutants. It should
be noted, however, that lack of observation of the monomer peak
does not indicate a predominantly aggregated sample. If one con-
siders a hypothetical mixture containing only 5- and 50-nm species,
due to thedependenceof light scattering intensity on the sixthpower
of the diameter, when 99% of the intensity arises from the 50-nm
species, this species will account for only 0.1% by mass of the total
protein in solution (35). Therefore, the DLS data indicate only
slight to moderate formation of soluble aggregates by reduced apo
SOD1 variants, consistent with the DSC and centrifugation data.
Discussion
The biophysical analyses conducted here show that ALS-associated
mutations have the most pronounced effects on stability in the
reduced apo form of SOD1 and enhance the formation of soluble
aggregates. These represent unique in-depth analyses of reduced
apo SOD1 stability and aggregation, and they have important impli-
cations for understanding mechanisms of SOD1 aggregation that
may be involved in ALS, considered further below.
In the Absence of ALS-Associated Mutations, Reduced apo SOD1 Is
Predominantly Folded and Has Low Aggregation Propensity Under
Physiologically Relevant Conditions.TheunfoldingofpWTmeasured
here by DSC and chemical denaturation is well fit by a reversible
two-statemonomerunfolding transition, basedonmultipleDSCand
chemicaldenaturationcriteria (Fig. 2C,Fig.S2DandE, andTable1),
and comparable results are obtained by DSC for WT (Fig. 2E and
Table 1). These results reveal that the ΔG of unfolding for reduced
apo SOD1 at 37 °C, which has not been reported previously, is
1.8 0.1 kcalmol−1 for pWT and 1.6 0.0 kcalmol−1 for WT.
Thus, at physiological temperature and pH, the protein is predomi-
nantly folded and shows very little tendency to aggregate.
The very minimal aggregation observed here for monomeric
reduced apo pWTandWT is particularly noteworthy given that pre-
vious studies have reported monomerization and loss of metals
greatly enhance, or are required for, aggregation (8, 37). Moreover,
several studies have reported observations of amyloid formation by
apo SOD1 in which the intramolecular disulfide bond was reduced
or removed by mutagenesis (8, 10, 14). A key difference between
these and the current studies is their use of agitation rather than
quiescent solution conditions. It is well established that agitation
promotes the aggregation of many proteins, often as amyloid
(8, 38, 39). This is not well understood but likely involves interface
effects and perhaps also accelerated oxidation of free thiols.
The relevance of the formation of amyloid aggregates in pre-
vious studies of reduced apo SOD1 to ALS disease mechanisms is
not clear. Other forms of SOD1 have also been shown previously
to form amyloid under destabilizing conditions caused by dena-
turant, sonication, trifluoroethanol, or low pH (8, 14, 20, 40), and
formation of intermolecular disulfide bonds (25). In contrast,
other studies under less extreme conditions have also reported
evidence for distinct aggregation processes from native-like states
(41–43). Protein aggregation is generally strongly dependent on
solution conditions, and many destabilizing and often nonphysio-
logical conditions can result in the formation of amyloid. In this
regard, it should be noted that the amyloid-specific characteristic
Fig. 3. Particle size distributions for reduced apo pWT and mutants at 37 °C,
pH 7.4measured by dynamic light scattering over time, as indicated in hours (H).
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of green–gold Congo red birefringence and ThT binding of
aggregates is not observed in ALS (5, 7) and the intracellular
SOD1-containing aggregates in fALS have a granule-coated
rather than the smooth fibrillar structure characteristic of amy-
loid (6); thus, ALS is not a typical amyloid disease.
A key aspect for in vitro studies of aggregation is to consider
their relation to in vivo conditions. Here we have used physiolo-
gically relevant conditions of temperature, pH, protein concentra-
tion, and quiescence. Importantly, the very minimal aggregation
of reduced apo pWT and WT is consistent with cell culture and
mice studies where wild-type SOD1 shows very little tendency
to aggregate andmice donot developALS symptoms (13, 17). This
differs from observations for mutant SOD1s, which tend to aggre-
gate more than WT in cell culture and form small aggregated
species in mice prior to the onset of symptoms followed by large
disulfide-linked aggregates in the final stages of disease (12, 13).
In contrast, in previous in vitro studies the comparable wild-type-
like constructs not only formed amyloid (8, 10, 14) but in some
cases this was more pronounced than for ALS-associated mutants
(10). This suggests fundamentally different aggregation processes
are being observed under different conditions.
ALS-Associated Mutations Have Complex Effects on Stability and
Aggregation. Under the physiologically relevant conditions used
herein, we were able to measure the effects of many chemically
and structurally diverse ALS-associated mutations on stability
and aggregation propensity. The effects on stability range from
slightly stabilizing to slightly or significantly destabilizing (Fig. 1C,
Table 1, and Table S2). Consistent with previous studies on apo
SOD1 where metal binding mutations had relatively small effects
on tm;app (44), the metal binding mutants H46R and G85R are
among the most stable mutants studied here. In the disulfide-
oxidized apo form, all the mutants have tm;app values well above
physiological temperature; however, in the reduced apo form,
most have tm;app values close to or lower than 37 °C, indicating
that they will be 50% or more unfolded at physiological tempera-
ture (Fig. 1D and Table S2). The observation that decreases in
melting temperatures tend to be largest in the reduced apo form
implies that substantial increases in the population of unfolded
conformations will also occur for many other mutants that have
been found to have decreased tm;app in the disulfide-oxidized apo
form (15, 24, 44). Thus, overall, many but not all ALS-associated
mutations are likely to significantly increase the population of
reduced apo unfolded monomers.
Regardless of stability, the DSC, AUC, and DLS experiments
indicate that the reduced apo mutants generally have increased
propensity to misfold/aggregate. In particular, DLS results indicate
that distinct sizes of small, soluble aggregates are observed fordiffer-
ent mutants (Fig. 3 and Figs. S4 and S5A). Evidence for structural
polymorphism of SOD1 aggregates was also reported for agitation-
induced aggregation (26). These findings are intriguing as variations
in aggregate structures may cause different disease phenotypes.
Limited Correlations Between the Properties of Reduced apo Mutant
SOD1s and ALS Characteristics Implicate Multiple Forms of SOD1 in
Modulating Disease. Correlations between the properties of
mutant SOD1 and ALS disease characteristics have been sought
for many years and are critical for deciphering disease mechan-
isms. Previous studies have reported evidence for a weak inverse
correlation between oxidized apo SOD1 stability and ALS dis-
ease duration (45–47), which improves when global or local pro-
tein characteristics such as charge (48) or hydrogen bonding (45)
are considered. The results for V148I suggest that increased hy-
drophobicity of the exposed dimer interface may be another sig-
nificant modulator of aggregation. A weak correlation is observed
between reduced apo mutant SOD1 stability and disease duration
(Fig. 4 and Fig. S6A), suggesting that the effects of the mutations
on the stability of reduced apo SOD1 do not play a more signifi-
cant role than their effects in oxidized apo in determining disease
duration. This implies that factors beyond stability, and multiple
forms of SOD1, are important in modulating disease duration.
There is a significant correlation (r ¼ 0.78, Fig. 4 and Fig. S6B)
between observed aggregation and mutant destabilization, consis-
tent with results of general studies of protein aggregation. This
has also been observed for more mature forms of SOD1 that tend
to aggregate more readily when destabilized (10, 11, 15, 16). The
aggregation observed here is poorly correlated with nine different
aggregation prediction models (Fig. S6E and SI Text). The lack of
correlations may be because most of these prediction algorithms
were developed based on datasets of amyloid-forming proteins
and peptides. As noted above, amyloid formation may differ
significantly from the formation of the soluble, nonamyloid aggre-
gates that are characterized here. There is also no significant
correlation between observed aggregation and ALS disease dura-
tion (Fig. 4 and Fig. S6C). Furthermore, the aggregation propen-
sities of the SOD1mutants predicted using the precedingmethods
are also poorly correlated with disease duration (Fig. S6D).
Consideration of these correlations points to two key conclu-
sions: Neither the association of reduced apo SOD1 mutants into
small soluble aggregates nor the predicted aggregation propensi-
ties of SOD1 mutants are able to account for fALS disease
duration. These key findings have two important implications:
(i) Multiple forms of SOD1 are likely to modulate disease char-
acteristics and (ii) amyloid formation is likely not an important
factor in SOD1-associated fALS. Further support for the first
point is evidence that mutations enhance the population and
aggregation of various immature forms of mutant SOD1, and
the observation of multiple forms of SOD1 in aggregates in vivo
(1, 13, 15, 16, 21, 41, 42, 49). The second point is further sup-
ported by evidence that fALS patient data fail to reveal any sup-
port for a role of amyloid in disease (7).
In conclusion, the results reported here provide unique and
important data on the stability and aggregate formation by
reduced apo SOD1s, which should prove useful for further testing
of ALS disease hypotheses. The increased aggregation of reduced
apo SOD1 upon mutation suggests that this form of the protein
may play a role in causing disease. However, the lack of strong
correlations between reduced apo SOD1 stability and disease
duration and between measured aggregation and disease dura-
tion imply that the effects of mutations on reduced apo SOD1
are unlikely to be the dominant factor in modulating disease, and
that multiple forms of the protein are involved. Unravelling the
complex aggregation processes that are likely to contribute to the
syndrome of ALS (50) may ultimately lead to new and urgently
needed approaches for treating this devastating disease.
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Fig. 4. A correlation plot representing the relationship between reduced
apo SOD1 mutant stability, fALS disease durations, and observed and pre-
dicted aggregation. The stability is determined by a change in apparent
tm of mutants compared to pWT and normalized, from 0 (least stable) to
1 (most stable). Observed aggregation is based on DLS measurements as
described in Fig. S5A. Predicted aggregation based on the Chiti et al. method
(52) was normalized from 0 (lowest propensity) to 1 (highest propensity).
Disease duration (47) is normalized from 0 (short) to 1 (long).
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Materials and Methods
Expression and Purification of Mutant SOD1. Disulfide-oxidized apo SOD1 pro-
teins were prepared as described previously (24, 51). Reduced apo SOD1 was
prepared by first unfolding the protein in 2 M GdmCl, 20 mM Hepes, pH 7.8
for 30 min at ambient temperature with degassing. Tris(2-carboxyethyl)phos-
phine hydrochloride (TCEP.HCl) was then added to a final concentration of
10 mMwith reduction occurring in an anaerobic environment for 1 h. Finally,
samples were exchanged into buffer containing 1 mM TCEP.HCl, 20 mM
Hepes pH 7.4 by successive dilutions and reconcentrations using a 3-kDa
cutoff Nanosep centrifugal device (Pall Corporation).
Differential Scanning Calorimetry. DSC scans of apo SOD1 samples were
performed as described elsewhere (15). After subtraction of buffer versus
buffer scans from protein versus buffer scans, disulfide-reduced apo SOD1
data were fit to a two-state monomer unfolding model after normalizing
for protein concentration (SI Text).
Light Scattering Measurements. Time average dynamic light scattering mea-
surements were performed using a Zetasizer Nano ZS (Malvern Instruments
Ltd.). Particle size was determined from an average of three correlation func-
tions, each being the average of five consecutive 10-s data accumulations.
Particle size was analyzed by the CONTIN method using Malvern software.
Samples were initially measured daily and then at increasing time intervals.
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Analysis of Differential Scanning Calorimetry (DSC) Thermal Unfolding
Data.Thermal unfolding scans for reduced apo superoxide dismu-
tase (SOD1) were fit to a two-state monomer unfolding model
(N ↔ U) using the following Eq. S1 (1):
CpðTÞ ¼ ðAþ BTÞð1 − f uÞ þ ðCþDTÞf u þ
βΔh2ðTÞf uð1 − f uÞ
RT2
;
[S1]
where CpðTÞ is the total specific heat capacity, normalized per
gram of protein, at temperature, T (in Kelvin), f u is the fraction
of unfolded protein at T, R is the universal gas constant, ΔhðTÞ is
the specific enthalpy of unfolding at T, A and B are the intercept
and slope of the native baseline, respectively, whereas C and D
are the intercept and slope of the unfolded baseline, respectively.
β is a temperature-independent constant equal to the molecular
weight of the dimer multiplied by the ratio of van’t Hoff to
calorimetric enthalpies of unfolding,ΔHvH∕ΔHcal. The DSC data
were fit to the approximate end of the unfolding transition due to
the occurrence of downward sloping posttransition baselines, pre-
sumably due to exothermic aggregation of the unfolded protein at
higher temperatures.
The baselines for scans obtained in urea for the determination
of the change in heat capacity upon unfolding, ΔCp, had higher
variability, which created problems in obtaining consistent fitted
values using Eq. S1. Accordingly, scans in urea were analyzed
using the commonly employed baseline subtraction with linear
connect (which effectively removes the influence of the base-
lines), followed by fitting of the resulting excess specific heat ca-
pacity, Cexp ðTÞ, normalized per mol of protein, to the MN2-state
model, Eq. S2 (Microcal Origin version 5.0) (2–5):
Cexp ðTÞ ¼
γΔH2ðTÞf uð1 − f uÞ
RT2
; [S2]
where ΔHðTÞ is the enthalpy of unfolding at T, f u is the fraction
of unfolded protein, and γ is ΔHvH∕ΔHcal. Fitted parameters for
reduced apo pWT datasets acquired in the absence of urea gave
fitted parameters that were very similar to those obtained using
Eq. S1 [<0.5 °C difference for tm (temperature in °C at which
f u ¼ 0.5) and <10% difference for ΔHvH and ΔHcal].
The fraction of unfolded protein can be determined from the
equilibrium constant, KðtÞ, at temperature, t (°C) using Eq. S3
and Eq. S4:
f u ¼
−1þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 8b
q
4
b
; [S3]
where
b ¼ KðtÞ
KðtmÞ
: [S4]
Calculation of Thermodynamic Parameters at 37 °C. ΔHðTÞ, ΔSðTÞ,
and ΔGðTÞ of thermal unfolding were calculated at 37 °C
(310.15 K) using a temperature independent ΔCp as previously
described (6) using the following equations:
ΔGðTÞ ¼ ΔHðTÞ − TΔSðTÞ; [S5]
ΔHðTÞ ¼ ΔHðTmÞ − ΔCpð310.15 − TmÞ; [S6]
ΔSðTÞ ¼ ΔSðTmÞ þ ΔCp ln

310.15
Tm

; [S7]
ΔSðTmÞ ¼
ΔHðTmÞ þ ΔGðTmÞ
Tm
; [S8]
and
ΔGðTmÞ ¼ −RTm lnP; [S9]
where P is the protein concentration of monomer subunits and
Tm is the temperature at which the protein is half unfolded.
Analytical Ultracentrifugation. Sedimentation velocity and equili-
brium experiments were conducted at the Biomolecular Interac-
tions & Conformations Facility (Shuclich School of Medicine
& Dentistry, University of Western Ontario) using an Optima
XL-A Analytical Ultracentrifuge (Beckman Coulter Inc.) with
an An60Ti rotor and 2∕6-channel cells with Epon-charcoal cen-
terpieces. Centrifugation was carried out at 20 °C, 20 mM Hepes,
1 mM Tris(2-carboxyethyl)phosphine (TCEP), pH 7.4, with ab-
sorbance detection at either 252 or 280 nm. Equilibrium data
were collected in radial step sizes of 0.002 cm and averaged over
10 readings. Equilibrium data were fit to a single ideal species
model (see below) using Prism 5 (GraphPad Software).
Analysis of Sedimentation Equilibrium Data. Data were analyzed
according to a single ideal species model as described elsewhere
(7), according to Eq. S10:
A ¼ Ao exp

ω2
2RT
MW obsð1 − ν¯ρÞðx2 − x2oÞ

þ I0; [S10]
where A is the absorbance at radius x, Ao is the absorbance
at reference radius xo, ω is the angular velocity of the rotor,
MW obs is the fitted molecular weight of the protein, ν¯ is the par-
tial specific volume of the protein, ρ is the density of the solvent,
and Io is the baseline offset.
Chemical Renaturation and Denaturation. Chemical renaturation
and denaturation equilibrium curves of reduced apo SOD1 were
prepared as described elsewhere (8), except that urea was used as
the denaturant instead of guanidinium chloride. All samples con-
tained 1 mM TCEP, 20 mM Hepes, pH 7.4 and were incubated
for 24 h at 25 °C in an anaerobic environment before measuring
circular dichroism (CD) at 216 and 231 nm using a J715 spectro-
polarimeter (Jasco Research Ltd.). Data were fit to a two-state
monomer unfolding model as described (9) according to Eq. S11:
Y obs ¼ fðYoN − SN ½urea − ½ðYoN − SN ½ureaÞ
− ðYoU − Su½ureaÞge
mð½urea−CmidÞ
RT ∕1þ emð½urea−Cmid ÞRT ; [S11]
where, Y obs is the observed optical signal, YoN and Y
o
u are the
native and unfolded signals, respectively, in the absence of urea,
and SN and SU describe the dependence of the native and
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unfolded signals with urea, respectively. m is a constant that de-
scribes the dependence of the free energy of unfolding (ΔGu) on
urea concentration and Cmid is the concentration of urea at the
midpoint of the curve, corresponding to the point at which
f u ¼ 0.5.
Acquiring Predicted Aggregation Propensities from a Variety of
Known Algorithms. In order to further investigate aggregation me-
chanisms, the following methods were used to compare predicted
mutant SOD1 aggregation with observed reduced apo mutant
SOD1 aggregation and disease duration: Chiti et al. (10) and
Wang et al. (11) methods, and online algorithms including Zyg-
gregator (http://www-vendruscolo.ch.cam.ac.uk/zyggregator.php)
(12), PASTA (http://protein.cribi.unipd.it/pasta/) (13), Waltz
(http://waltz.switchlab.org/) (14), TANGO (http://tango.crg.es/)
(15), FoldAmyloid (http://antares.protres.ru/fold-amyloid/oga.cgi)
(16), and Profile3D (http://services.mbi.ucla.edu/zipperdb/) (17).
Predictions were made for pseudo WT (pWT) and all 12 mutants
presented in this study. Additionally, 13 extra mutants with disease
duration averages based on 5 or more patients (11) were predicted
and included in the correlations for disease duration. All results
were compared to pWT and no convincing correlations between
predicted aggregation propensity and observed aggregation or fa-
milial amyotrophic lateral sclerosis (fALS) disease duration were
observed.
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Fig. S1. (A) Ribbon representation of holo SOD1 (PDB ID code 1HL5) (1). Each monomer binds one zinc and one copper ion, indicated by black and gold
spheres, respectively. The locations of C57 and C146, which form the intramolecular disulfide bond in each monomer, are shown in green. The sites of the fALS-
associated mutations that were investigated in this study (A4, G37, H43, H46, G85, G93, E100G, and V148) are shown in red. The fALS mutations are dispersed
throughout the structure of SOD1 and have a range of structural contexts. H46R and G85R (2, 3) alter metal binding, A4S, A4T, A4V, and V148 are located in the
dimer interface, G93S, A, and R are in a tight turn, G37R and H43R disrupt packing in the β-barrel (4, 5), and E100G removes a salt bridge with K30 (6). Residues
C6 and C111 are mutated to A and S, respectively, in the pWTconstruct and are shown in yellow. The figure was rendered using Pymol. (B) SDS-PAGE of reduced
apo SOD1 before and after DSC experiments. The gel contained 12% acrylamide and was visualized by staining with Coomassie Blue. Lane 1 is a lowmolecular
weight marker with molecular weights as indicated. Lanes 2 and 6 are disulfide-intact apo SOD1 controls, whereas lane 3 is apo SOD1 with disulfide reduced by
β-mercaptoethanol. Lanes 4 and 5 are reduced apo SOD1 in 20 mM Hepes, 1 mM TCEP, pH 7.4 before and after DSC scanning, respectively. These samples were
treated with iodoacetamide prior to loading on the gel to prevent free cysteines from being oxidized on the gel (7). Samples, both before and after each
experiment, were found to run much closer to the disulfide-reduced control in lane 3 than the oxidized controls in lanes 2 and 6, indicating that the samples
remained fully reduced throughout each experiment.
1. Strange RW, et al. (2003) The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J Mol Biol
328:877–891.
2. Antonyuk S, et al. (2005) Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg. Protein Sci 14:1201–1213.
3. Cao X, et al. (2008) Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis. J Biol Chem 283:16169–16177.
4. DiDonato M, et al. (2003) ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol 332:601–615.
5. Hart PJ, et al. (1998) Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein Sci 7:545–555.
6. Rumfeldt JA, Stathopulos PB, Chakrabarrty A, Lepock JR, Meiering EM (2006) Mechanism and thermodynamics of guanidinium chloride-induced denaturation of ALS-associated
mutant Cu,Zn superoxide dismutases. J Mol Biol 355:106–123.
7. Furukawa Y, O’Halloran TV (2005) Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and
oxidative aggregation. J Biol Chem 280:17266–17274.
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Fig. S2. (A) Protein concentration dependence of reduced apo pWT thermal unfolding. DSC endotherms were collected in 20mMHepes, 1 mM TCEP, pH 7.4 at
different protein concentrations as indicated (in mg mL−1). There is no concentration dependent shift to higher temperatures of unfolding, as expected for a
monomer. The data (solid black lines) over the >20-fold concentration range are well fit (broken grey lines) by a monomer two-state unfolding model
(SI Materials and Methods, Eq. S1). Fitted parameters are given in Table S1. (B) Kirchoff plot analysis of ΔCp. The ΔHvH values were obtained from two-state
monomer fitting of pWT DSC data collected in the presence of urea (see D and E). The ΔHvH data are well fit by linear regression (r ¼ 0.967) giving a ΔCp value
from the slope of 1.1 0.1 kcal mol−1 °C−1. (C) Reduced apo pWT DSC scans in urea. Baselines generated by the linear connect method in Origin 5.0 (Microcal)
were subtracted from raw data and normalized for protein concentration, prior to fitting data to a two-state monomer unfolding model (SI Materials and
Methods, Eq. S1). Fits (broken grey lines) are shown for data (solid black lines) collected in 20 mM Hepes, 1 mM TCEP, pH 7.4 with 0.25, 0.5, 0.75, 0.875, 1, and
1.25 M urea (Top to Bottom) as indicated. ΔHvH values from the fits are plotted in Fig. S2A. (D and E) Equilibrium urea renaturation and denaturation curves for
reduced apo SOD1 at 25 °C. Data for pWT are shown in blue and data for H46R are shown in black. Protein concentrations for the curves are 8.5 μM
(0.13 mgmL−1) (circles), 14 μM (0.22 mgmL−1) (triangles), and 24 μM (0.38 mgmL−1) (diamonds). Denaturation and renaturation data are plotted as closed
and open symbols, respectively. CD data for each protein at (D) 216 nm and (E) 231 nmwere globally fit to a two-state monomer unfoldingmodel with Cmid and
m as shared parameters (SI Materials andMethods, Eq. S11). pWTand H46R yielded similarm values with the average being 2.49 0.30 kcalmol−1, whereas the
midpoint of denaturation (Cmid) for pWTwas 1.63 0.07 M and 2.04 0.04 M for H46R, corresponding to ΔG of 4.0 0.2 kcalmol−1 and 5.1 0.1 kcal mol−1
for pWT and H46R, respectively (Table 1).
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Fig. S3. Van Holde–Weischet analysis (1) of sedimentation velocity analytical ultracentrifugation experiments for reduced apo pWT and H43R SOD1. Experi-
ments were conducted in 20 mM Hepes, 1 mM TCEP, pH 7.4 at 20 °C using an Optima XL-A Analytical Ultracentrifuge (Beckman Coulter Inc.) with an An60Ti
rotor and two channel cells with Epon-charcoal centerpieces and absorbance detection at 280 nm. All velocity data were acquired at 50,000 rpm with mea-
surements (average of three readings) collected at radial step sizes of 0.003 cm; scans were taken at 10-min intervals for a total of 30 scans. Data were analyzed
using the program Sedfit (2). The initial absorbances at 280 nm were 0.29 and 0.33 for pWT and H43R, respectively.
1. van Holde KE, Weischet, WO (1978) Boundary analysis of sedimentation velocity experiments with monodisperse and paucidisperse solutes. Biopolymers 17:1387–1403.
2. Schuck P (2007) Sedimentation equilibrium analytical ultracentrifugation for multicomponent protein interactions. Protein Interactions: Biophysical Approaches for the Study of
Complex Reversible Systems, ed Atassi MZ (Springer, New York), Vol 5, pp 289–316.
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Fig. S4. Particle size distributions for reduced apo (A) A4S, (B) A4T, (C) G37R, (D) H46R, (E) wtH46R, (F) G85R, (G) G93A, (H) G93R, and (I) E100G as a function of
incubation time in hours (H). Samples contained ∼1 mgmL−1 protein in 20mMHepes, 1 mM TCEP, pH 7.4. The differing aggregation tendencies of each mutant
are shown. The monomer remains the dominant species and after incubating G85R, H46R, and wtH46R for ∼300 h, whereas diminishedmonomer intensity and
varying amounts of larger species form after incubating A4S, A4T, G37R, G93A, G93R and E100G under the same conditions. There is no significant difference in
the aggregation behavior of H46R in the pWT and WT background.
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Fig. S5. (A) To address reproducibility, each DLS experiment was repeated between two and five times and the percent of total light scattering intensity after
incubation for ∼300 h arising from species with a hydrodynamic diameter larger than 20 nm (dark blue bars) and 200 nm (light blue bars) was compared. The
reproducibility of each DLS experiment is reflected by the error bars. (B–D) Change in light scattering intensity [in kilocounts per second (kcps)] as a function of
incubation time is shown for all mutants studied. All values plotted are an average of three measurements at each time point shown over the duration of the
time course. The data acquired for each mutant were categorized into three plots: (B) mutants that showed significant aggregation, (C) mutants that show
evidence for slight to moderate increased aggregation tendencies, and (D) mutants that showed very little to no evidence of aggregation.
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Fig. S6. A correlation plot of reduced apo SOD1 mutant stability, observed aggregation, predicted aggregation propensity and disease duration. Stability is
represented as the change in tm;app for reduced apo SOD1 upon mutation. Observed aggregation values are based on light scattering intensity at the end of
each mutant SOD1 DLS time course (see Fig. S5A). Predicted aggregation was assessed for SOD1 mutants based on the Chiti et al. method (10). Aggregation
values are normalized in such a way that 1 represents the most aggregation and 0 represents the least aggregation. Finally, disease duration is based on
summarized data by Wang et al. (11) and is normalized so that 1 represents mutants with the longest disease durations and 0 represents mutants with
the shortest disease durations. (A) A poor correlation is observed between mutant reduced apo SOD1 stability and disease duration. (B) Increased observed
reduced apo SOD1 aggregation correlates well with a decrease in mutant stability. Disease duration is poorly correlated with observed reduced apo SOD1
aggregation (C) and predicted SOD1 aggregation (D). (E) There is no correlation between observed and predicted aggregation. Refer to Table S2.
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Table S1. DSC monomer two-state unfolding fitted parameters for disulfide-reduced apo superoxide dismutases (SOD1s)
apo reduced
SOD1
[Protein],
mg∕mL
tm,*
°C
ΔCpðtmÞ,†
kcalðmolÞ−1 °C−1
ΔHvHðtmÞ,‡
kcalðmolÞ−1
ΔHcalðtmÞ,‡
kcalðmolÞ−1 ΔHvH∕ΔHcal
pWT 0.11 47.3 ± 0.1 1.12 63.5 ± 1.7 47.9 ± 0.8 1.33
pWT 0.25 47.0 ± 0.5 1.66 60.4 ± 1.1 62.6 ± 0.7 0.96
pWT 0.42 47.4 ± 0.3 0.88 63.2 ± 2.8 52.4 ± 1.9 1.21
pWT 0.48 47.8 ± 0.6 0.80 62.5 ± 5.4 59.4 ± 4.0 1.05
pWT 0.53 47.5 ± 0.0 0.71 60.2 ± 0.6 60.2 ± 0.4 1.00
pWT 0.55 48.8 ± 0.0 −0.27 60.6 ± 0.7 59.8 ± 0.4 1.01
pWT 0.93 47.7 ± 0.3 0.27 62.7 ± 3.2 51.2 ± 1.9 1.22
pWT 2.30 47.5 ± 0.1 0.61 59.8 ± 1.7 44.6 ± 0.8 1.34
Avg ± SD§ 47.6 ± 0.5 0.72 ± 0.57 61.6 ± 1.5 54.8 ± 6.6 1.14 ± 0.15
H46R 0.33 52.3 ± 0.1 −0.05 77.1 ± 2.1 75.6 ± 1.2 1.02
H46R 0.48 52.5 ± 0.0 0.17 70.5 ± 0.8 80.9 ± 0.1 0.87
H46R 0.57 53.2 ± 0.2 −1.39 70.5 ± 2.9 73.2 ± 1.6 0.96
Avg ± SD§ 52.6 ± 0.5 −0.42 ± 0.84 72.7 ± 3.8 76.5 ± 4.0 0.95 ± 0.08
V148I 0.74 51.8 ± 0.9 −3.46 56.6 ± 9.4 58.4 ± 3.8 0.97
V148I 0.89 50.3 ± 0.1 −1.77 60.3 ± 1.3 67.0 ± 0.8 0.90
Avg ± SD§ 51.0 ± 1.1 −2.62 ± 1.19 58.4 ± 2.6 62.7 ± 6.1 0.93 ± 0.05
G85R 0.17 40.6 ± 2.0 −0.46 52.2 ± 13.9 74.3 ± 13.2 0.70
G85R 0.38 40.4 ± 0.6 0.22 50.9 ± 3.8 47.1 ± 2.5 1.08
G85R 1.42 41.2 ± 0.2 −0.11 49.3 ± 1.5 35.0 ± 0.7 1.41
Avg ± SD§ 40.7 ± 0.4 −0.11 ± 0.34 50.8 ± 1.5 52.3 ± 20.2 1.06 ± 0.36
E100G 0.43 35.0 ± 0.1 0.32 42.2 ± 1.0 32.8 ± 0.4 1.24
E100G 0.49 32.7 ± 1.1 0.87 45.5 ± 6.8 37.9 ± 4.8 1.20
E100G 0.75 33.0 ± 0.1 0.89 43.4 ± 1.3 32.3 ± 0.7 1.34
E100G 0.80 32.1 ± 0.1 1.07 42.1 ± 1.2 32.6 ± 0.5 1.29
Avg ± SD§ 33.2 ± 1.2 0.79 ± 0.32 43.3 ± 1.4 34.3 ± 2.6 1.27 ± 0.06
WT 0.34 46.5 ± 0.0 0.53 57.9 ± 1.0 34.7 ± 0.25 1.68
WT 0.30 47.1 ± 0.7 1.48 56.4 ± 7.4 43.3 ± 3.75 1.30
Avg ± SD§ 46.8 ± 0.4 1.01 ± 0.67 57.2 ± 1.1 39.0 ± 6.1 1.49 ± 0.27
WT H46R 0.50 50.4 ± 0.0 −1.86 55.5 ± 0.9 64.9 ± 0.63 0.86
WT H46R 0.50 52.5 ± 0.2 −0.40 63.6 ± 1.6 70.9 ± 1.26 0.90
WT H46R 0.50 52.6 ± 0.6 −0.77 64.4 ± 6.0 85.2 ± 5.19 0.76
Avg ± SD§ 51.8 ± 1.3 −1.01 ± 0.76 61.2 ± 4.9 73.7 ± 10.4 0.84 ± 0.07
*Errors (±) from the fitting program (Microcal Origin, version 5.0).
†Errors from individual fits could not be reliably determined because they are based on uncertainties in five independent variables.
‡Errors derived using standard procedures (1) from errors in fitted ΔhcalðtmÞ and β returned by the fitting program.
§Average and standard deviation.
1. Taylor JR (1982) An Introduction to Error Analysis (University Science Books, Mill Valley, CA).
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Table S2. Stability and aggregation summary for disulfide-reduced apo SOD1s
apo
SOD1
tm
(disulfide-reduced),*
°C
Δtm
(disulfide-reduced),†
°C
Δtm
(disulfide-oxidized),†,‡
°C
Disease
duration,
y§
Predicted
aggregation
propensity¶
Predicted
aggregation
propensity +
instability∥
Observed
aggregation
propensity**
H46R 52.8 ± 0.4 +4.3 +3.0 17.6 0.28 0.00 0.00
V148I 50.0 ± 0.1 +1.5 +1.4 1.7 0.45 0.20 0.11
pWT 48.5 ± 0.3 NA NA NA 0.56 0.32 0.06
G85R 41.2 ± 0.3 −7.3 −3.8 6.0 0.25 0.34 0.13
A4V 36.3 ± 0.2 −12.2 −8.9 1.2 1.00 1.0 0.96
H43R 35.4 ± 0.4 −13.1 −10.7 1.8 0.00 0.35 1.00
G93R 35.4 ± 1.8 −13.1 −10.1 5.3 0.16 0.46 0.70
E100G 35.3 ± 0.7 −13.2 −7.7 4.7 0.93 0.98 0.56
G93A 34.6†† −14.9 −10.3 3.1 0.54 0.77 0.42
G37R 33.5 ± 1.2 −15.0 −9.7 17 0.25 0.58 0.88
G93S 33.4 ± 1.2 −15.1 −8.6 8.0 0.50 0.75 0.53
A4S 32.5†† −16.0 −13.0 NA 0.39 0.70 0.45
A4T 30.9 ± 0.3 −17.6 −14.9 1.5 0.56 0.87 0.82
NA, not applicable.
*Values are the apparent melting temperature where the observed Cp in the DSC scan is a maximum. The values listed are the average of at least two
independent measurements unless otherwise noted.
†Calculated as tm;app mutant −tm;appWT, negative values indicate destabilization.
‡Δtm;app data for A4V, G85R, E100G, G93S, and G93Rwere obtained from (6, 8). TheΔtm;app for H46R, V148I, H43R, G93A, G37R, A4S, and A4Twas obtained
from scans acquired in this study.
§Average disease durations are from Wang et al. (11).
¶Predicted aggregation propensities were calculated relative to pWTusing the Chiti-Dobsonmethod (10) and normalized using themethodology ofWang
et al. (11), where 0 indicates low aggregation propensity and 1 indicates high aggregation tendency.
∥Δtm;app incorporated into the predicted aggregation propensity as described by Wang et al. (11), and aggregation scores were normalized over a scale
from 0 to 1.
**Observed aggregation propensity is based on intensity statistics from DLS measurements as shown in Fig. S5A.
††tm;app based on one measurement.
Table S3. Single species model fitting of analytical ultracentrifugation sedimentation equilibrium
data
Sample and concentrations
Best fit molecular weight (kDa) ± standard error at different
rotor speeds
Apo reduced SOD [SOD], mg∕mL 20,000 rpm 25,000 rpm 30,000 rpm 35,000 rpm
pWT 1.0 15.2 ± 0.4 15.0 ± 0.2 14.3 ± 0.2 13.5 ± 0.2
pWT 1.0 14.3 ± 0.3 15.1 ± 0.3 15.2 ± 0.2 14.1 ± 0.1
pWT 1.5 14.4 ± 0.3 15.6 ± 0.2 14.4 ± 0.1 12.4 ± 0.1
E100G 0.8 22.5 ± 0.4 21.3 ± 0.2 19.3 ± 0.2 17.5 ± 0.1
E100G 1.0 20.3 ± 0.4 19.3 ± 0.3 17.4 ± 0.2 16.6 ± 0.2
E100G 1.5 20.2 ± 0.3 19.3 ± 0.2 17.8 ± 0.2 16.4 ± 0.1
A4V 0.8 24.2 ± 0.6 21.1 ± 0.3 18.2 ± 0.2 16.5 ± 0.1
H43R 1.0 36.6 ± 0.6 31.6 ± 0.6 23.2 ± 0.3 19.8 ± 0.2
H43R 1.0 33.6 ± 0.4 28.4 ± 0.3 23.2 ± 0.2 20.5 ± 0.1
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